Westonci.ca offers quick and accurate answers to your questions. Join our community and get the insights you need today. Explore comprehensive solutions to your questions from a wide range of professionals on our user-friendly platform. Explore comprehensive solutions to your questions from a wide range of professionals on our user-friendly platform.
Sagot :
Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinoma.
- In this study, we assess the effectiveness of autologous cytokine-induced killer cells (CIK) transfusion combined with gemcitabine and cisplatin (GC) chemotherapy for the treatment of nasopharyngeal cancer in patients with distant metastases following radiotherapy.
- As a result, our study suggested that patients with postradiotherapy distant nasopharyngeal carcinoma metastases may benefit better from CIK cell transfusion therapy combined with GC chemotherapy.
- While the 30 patients in the GC group only received GC chemotherapy, the 30 patients in the GC+CIK group also received an adoptive autologous CIK cell transfusion.
To learn more about chemotherapy.
brainly.com/question/12147641
#SPJ4
We appreciate your time. Please come back anytime for the latest information and answers to your questions. Thank you for choosing our platform. We're dedicated to providing the best answers for all your questions. Visit us again. Get the answers you need at Westonci.ca. Stay informed with our latest expert advice.
